Answers are grounded in this paper and cite their sources.
Double-masking study assesses mydriatic and cycloplegic effects of tropicamide in various doses, suggesting effective treatment options.
Using double‐masking procedures, the mydriatic and cycloplegic effects of 0.25, 0.5, 0.75, and 1.0% tropicamide were studied. All doses produced clinically useful mydriasis of at least 6‐mm pupils. Using testing conditions of both normal (35 ft‐c) and bright (150 ft‐c) illumination, no mydriatic dose‐response differences for the four concentrations were found. Cycloplegic effects were dose related. A single drop of either 0.75 or 1.0% tropicamide reduced the amplitude of accommodation to about 1.5 D, which is adequate for a cycloplegic refraction.
No takes yet. Share an insight, caveat, or question.
Pollack et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: